Eli Lilly & Co. (LLY) Reports In-Line Q3 EPS; Narrows FY11 EPS Outlook
Tweet
Share
E-mailGet Alerts LLY Hot Sheet
Price: $1,224.24 -0.63%
Financial Fact:
Dividends paid per share: 0.51
Today's EPS Names:
ECX, ONON, LODE, More
Financial Fact:
Dividends paid per share: 0.51
Today's EPS Names:
ECX, ONON, LODE, More
Join SI Premium – FREE
Eli Lilly & Co. (NYSE: LLY) reported Q3 EPS of $1.13, in-line with the analyst estimate of $1.13. Revenue for the quarter came in at $0 versus the consensus estimate of $6.06 billion.
Eli Lilly & Co. sees FY2011 EPS of $4.30-$4.35, versus prior guidance of $4.25-$4.35 and the consensus of $4.33.
Eli Lilly & Co. sees FY2011 EPS of $4.30-$4.35, versus prior guidance of $4.25-$4.35 and the consensus of $4.33.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- 908 Devices Inc. (MASS) Misses Q2 EPS by 17c ; Offers Guidance
- Zura Bio (ZURA) Misses Q2 EPS by 2c
- Eli Lilly's weight-loss pill secures first European nod in Britain
Create E-mail Alert Related Categories
Earnings, GuidanceSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
